A Multi-centre Real-world Non-interventional Observational Study to Evaluate Clinical Characteristics of the Chinese Patients With Lung Malignant Tumors Who Received Surgeries or Surgeries Plus Adjuvant Therapies
Overview
- Phase
- Not Applicable
- Intervention
- Not specified
- Conditions
- Lung Cancer
- Sponsor
- West China Hospital
- Enrollment
- 21777
- Locations
- 10
- Primary Endpoint
- Demographic characteristics of the patients with lung malignant tumors who received surgeries
- Status
- Completed
- Last Updated
- 7 years ago
Overview
Brief Summary
The study was designed to evaluate effectiveness of the surgeries and adjuvant therapies after surgeries in the patients with lung malignant tumors
Detailed Description
The trial is a multi-centre real-world non-interventional observational study to evaluate effectiveness of the surgeries and adjuvant therapies after surgeries in the patients with lung malignant tumors via a retrospectively review method on the study data on patient demographic/tumor biological characteristics and clinical treatments.
Investigators
Lunxu Liu
Professor
West China Hospital
Eligibility Criteria
Inclusion Criteria
- •Age \>= 18 years old;
- •Pathologically diagnosed lung malignant tumors after surgeries;
- •Patients with lung surgeries;
- •Patients with complete medical health records and follow-up visit information (at least one follow-up visit);
Exclusion Criteria
- •Patients who were not performed with surgeries;
- •Pathologically diagnosed patients with benign diseases after surgeries;
Outcomes
Primary Outcomes
Demographic characteristics of the patients with lung malignant tumors who received surgeries
Time Frame: 2014 - 2017
Demographic characteristics of the patients with lung malignant tumors who received surgeries of thoracotomy, video-assistant thoracic surgery or robotic thoracic surgery as measured by: * Age * Gender * Payment types * Insurance types * Smoking history * Complications and symptoms of complications * Respiratory functions * Type of diagnoses
Secondary Outcomes
- Location of tumors and tumor sizes(2014 - 2017)
- Type of biomarkers(2014 - 2017)
- Tumor clinical/pathological staging(2014 - 2017)